138 related articles for article (PubMed ID: 9684188)
1. Efficacy and safety of oral immunotherapy in respiratory allergy to Parietaria judaica pollen. A double-blind study.
Ariano R; Panzani RC; Augeri G
J Investig Allergol Clin Immunol; 1998; 8(3):155-60. PubMed ID: 9684188
[TBL] [Abstract][Full Text] [Related]
2. Monitoring of specific IgG4 antibodies in respiratory allergy due to the pollen of Parietaria judaica. Evidence for a protective role.
Panzani RC; Ariano R; Augeri G
Allergol Immunopathol (Madr); 1996; 24(6):263-8. PubMed ID: 9010562
[TBL] [Abstract][Full Text] [Related]
3. Double-blind placebo controlled specific immunotherapy with mixed Cupressaceae taxodiaceae pollens in respiratory allergy to Cupressus sempervirens.
Ariano R; Panzani RC; Augeri G
Allergol Immunopathol (Madr); 1997; 25(1):23-9. PubMed ID: 9111873
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy with sublingual birch pollen extract. A short-term double-blind placebo study.
Horak F; Stübner P; Berger UE; Marks B; Toth J; Jäger S
J Investig Allergol Clin Immunol; 1998; 8(3):165-71. PubMed ID: 9684190
[TBL] [Abstract][Full Text] [Related]
5. Possible relationship between systemic side effects and sensitization to rPar j 2 in allergic patients submitted to an ultra-rush (20 min) sublingual immunotherapy and selected by component resolved diagnosis.
Rossi RE; Monasterolo G; Coco G; Operti D
Int Arch Allergy Immunol; 2005 Oct; 138(2):105-10. PubMed ID: 16174987
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy with an alum-adsorbed Parietaria-pollen allergoid: a 2-year, double-blind, placebo-controlled study.
Tari MG; Mancino M; Ghezzi E; Frank E; Cromwell O
Allergy; 1997 Jan; 52(1):65-74. PubMed ID: 9062631
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the efficacy and safety of two preseasonal regimens of glutaraldehyde modified, tyrosine-adsorbed parietaria pollen extract over a period of three years in monosensitive patients.
Negro JM; Wheeler AW; Hernández J; Youlten LJ; Pascual A; García-Sellés FJ; Pagán JA; López-Sánchez JD; Miralles JC; Sarrió F; Milán JM; Contreras LG; Vidal D
Allergol Immunopathol (Madr); 1999; 27(3):153-64. PubMed ID: 10431101
[TBL] [Abstract][Full Text] [Related]
8. Desensitization effect of preseasonal seven-injection allergoid immunotherapy with olive pollen on basophil activation: the efficacy of olive pollen-specific preseasonal allergoid immunotherapy on basophils.
Gokmen NM; Ersoy R; Gulbahar O; Ardeniz O; Sin A; Unsel M; Kokuludag A
Int Arch Allergy Immunol; 2012; 159(1):75-82. PubMed ID: 22572984
[TBL] [Abstract][Full Text] [Related]
9. Pollinex Parietaria (Bencard Parietaria), a new allergoid for treatment of patients sensitive to Parietaria pollen.
Resta O; Carnimeo N; Foschino MP; Taylor I; Wheeler AW; Youlten LJ
J Investig Allergol Clin Immunol; 1991 Apr; 1(2):129-37. PubMed ID: 1669569
[TBL] [Abstract][Full Text] [Related]
10. A randomized, controlled study of specific immunotherapy in monosensitized subjects with seasonal rhinitis: effect on bronchial hyperresponsiveness, sputum inflammatory markers and development of asthma symptoms.
Crimi N; Li Gotti F; Mangano G; Paolino G; Mastruzzo C; Vancheri C; Lisitano N; Polosa R
Ann Ital Med Int; 2004; 19(2):98-108. PubMed ID: 15317270
[TBL] [Abstract][Full Text] [Related]
11. Clinical efficacy and safety of a depigmented and glutaraldehyde polymerized therapeutic vaccine of Parietaria judaica.
García-Sellés J; Pascual A; Funes E; Pagán JA; López JD; Negro JM; Hernández J
Allergol Immunopathol (Madr); 2003; 31(2):63-9. PubMed ID: 12646120
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy with Alpare in patients with respiratory allergy to Parietaria pollen: a two year double-blind placebo-controlled study.
D'Amato G; Kordash TR; Liccardi G; Lobefalo G; Cazzola M; Freshwater LL
Clin Exp Allergy; 1995 Feb; 25(2):149-58. PubMed ID: 7750007
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy with a depigmented, polymerized vaccine of Olea europaea pollen allergens. Significantly reduces specific bronchial and skin test reactivity in sensitized patients after one year of treatment.
Guerra F; Daza JC; Almeda E
J Investig Allergol Clin Immunol; 2003; 13(2):108-17. PubMed ID: 12968395
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of sublingual coseasonal immunotherapy with a monomeric allergoid in Cupressaceae pollen allergy--preliminary data.
Ariano R; Panzani RC; Mistrello G
Eur Ann Allergy Clin Immunol; 2005 Mar; 37(3):103-8. PubMed ID: 15918297
[TBL] [Abstract][Full Text] [Related]
15. The type of sensitizing allergen can affect the evolution of respiratory allergy.
Marogna M; Massolo A; Berra D; Zanon P; Chiodini E; Canonica GW; Passalacqua G
Allergy; 2006 Oct; 61(10):1209-15. PubMed ID: 16942571
[TBL] [Abstract][Full Text] [Related]
16. Hyposensitization therapy of Parietaria-sensitive patients with a tyrosine adsorbed allergoid, Pollinex Parietaria (Bencard Parietaria).
Bonifazi F; Antonicelli L; Bilò MB; Pucci S; Taylor IH; Wheeler AW; Youlten LJ
J Investig Allergol Clin Immunol; 1991 Feb; 1(1):37-44. PubMed ID: 1669563
[TBL] [Abstract][Full Text] [Related]
17. [Immunotherapy with an oral Alternaria extract in childhood asthma. Clinical safety and efficacy and effects on in vivo and in vitro parameters].
Criado Molina A; Guerra Pasadas F; Daza Muñoz JC; Moreno Aguilar C; Almeda Llamas E; Muñoz Gomariz E; Font Ugalde P; Alonso Díaz C; Germán Cárdenas M; Sánchez Guijo P
Allergol Immunopathol (Madr); 2002; 30(6):319-30. PubMed ID: 12464165
[TBL] [Abstract][Full Text] [Related]
18. Nasal immunotherapy at constant dosage: a double-blind, placebo-controlled study in grass-allergic rhinoconjunctivitis.
Pocobelli D; Del Bono A; Venuti L; Falagiani P; Venuti A
J Investig Allergol Clin Immunol; 2001; 11(2):79-88. PubMed ID: 11642577
[TBL] [Abstract][Full Text] [Related]
19. Rush sublingual immunotherapy in Parietaria allergic patients.
D'Ambrosio FP; Ricciardi L; Isola S; Savi E; Parmiani S; Puccinelli P; Musarra A
Allergol Immunopathol (Madr); 1996; 24(4):146-51. PubMed ID: 8939269
[TBL] [Abstract][Full Text] [Related]
20. Local intranasal immunotherapy with allergen in powder in atopic patients sensitive to Parietaria officinalis pollen.
Ariano R; Panzani RC; Chiapella M; Augeri G; Falagiani P
J Investig Allergol Clin Immunol; 1995; 5(3):126-32. PubMed ID: 7582157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
